Skip to main content
. 2021 Nov 3;7(1):1–9. doi: 10.1001/jamacardio.2021.4458

Figure 1. Summary of Ryanodine Receptor 2 (RyR2)–Calcium-Release Deficiency Syndrome (CRDS) Case Ascertainment and Outcomes in the Multicenter Cohort.

Figure 1.

CPVT indicates catecholaminergic polymorphic ventricular tachycardia; GOF, gain of function; LOF, loss of function; PVC, premature ventricular complex; and WT, wild-type.